Results 61 to 70 of about 40,271 (232)

Histological Changes of Maternal Risperidone and Folic acid on the Cerebellar Cortex of the Offspring of the Albino Rat [PDF]

open access: yesThe Egyptian Journal of Histology, 2019
Background: Risperidone is atypical, second-generation antipsychotic and folic acid is a water-soluble B vitamin.Objective: Assessment of the effect of risperidone on the development of the cerebellar cortex of albino rats, and evaluation of the ...
safaa Hanafy
doaj   +1 more source

Systematic Review of the Huntington's Disease Drug Development Pipeline, 2014 to 2025

open access: yesMovement Disorders, EarlyView.
Abstract Background In the past decade, significant advances have improved our understanding of the mechanisms underlying HD pathobiology leading to several putative therapeutic targets for HD. Objective The aim was to describe the Huntington's disease (HD) drug development clinical pipeline.
Pavlina Konstantinova   +5 more
wiley   +1 more source

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia

open access: yesFrontiers in Psychiatry, 2020
ObjectiveTo explore the association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with risperidone-induced weight gain.MethodsWe analyzed the association between MTHFR C677T polymorphism and risperidone-induced weight gain in 356 ...
Jingping Liao   +13 more
doaj   +1 more source

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort

open access: yesMovement Disorders, EarlyView.
Abstract Background Intracerebral gene therapy is effective for amino acid decarboxylase (AADC) deficiency, but relationships between anatomical putaminal coverage, metabolic dynamics, and clinical recovery remain poorly understood. Objectives Assess safety, long‐term efficacy, and clinical–radiological correlations in a genetically diverse European ...
Clément Dunoyer   +27 more
wiley   +1 more source

Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia

open access: yes, 2011
Antipsychotic medication is considered the cornerstone of the treatment in elderly patients with schizophrenia. Long acting risperidone injection was the first antipsychotic available for use in this group of patients.
Rosa Catalán, Rafael Penadés
core   +1 more source

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study [PDF]

open access: yes, 2010
Adel GabrielDepartments of Psychiatry and Community Health Sciences, University of Calgary, Alberta, CanadaBackground: There is a great need in the treatment of schizophrenia for a drug, or drug ­combinations, to improve clinical response with ...
Adel Gabriel, Gabriel, Adel A.R.
core   +1 more source

Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting

open access: yesPM&R, EarlyView.
Abstract Background Adolescents and adults with cerebral palsy often experience multimorbidity related to their condition, which primarily affects movement and posture but is also associated with pain, epilepsy, mood disorders, and other conditions. As such, these patients are often prescribed a range of medications to manage symptoms, thereby putting ...
Caitlin Cassidy   +3 more
wiley   +1 more source

The effects of risperidone, an atypical antipsychotic, on the reeler mutant mouse, a potential model of schizophrenia [PDF]

open access: yes, 2006
"The reeler mutant mouse (rl/rl) has been proposed to be a behavioral model of schizophrenia. The purpose of the current research was to study the effects of the antipsychotic, risperidone, on the rl/rl, because if the rl/rl models schizophrenia, then ...
Goode, Amanda K.   +1 more
core  

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson   +13 more
wiley   +1 more source

Risperidone-induced reversible neutropenia

open access: yes, 2017
Vasanth Kattalai Kailasam,1 Victoria Chima,2,* Uchechukwu Nnamdi,3,* Kavita Sharma,4,* Kairav Shah5 1College of Medicine, University of Illinois, Chicago, IL, USA; 2Mount Sinai Beth Israel Medical Center, New York, NY, USA; 3Albert Einstein College of ...
Kattalai Kailasam V   +4 more
core  

Home - About - Disclaimer - Privacy